Gaudium IVF and Women Health Limited IPO Review
Neutral75-79 · Mainboard
✦
Analyst Verdict
Gaudium IVF and Women Health Limited IPO
Neutral
IPO at a Glance
Price Band
75-79
Issue Size
165cr
Min. Investment
₹14,931
Opens
2026-02-18
Closes
2026-02-22
Listing
2026-02-25
Category
Mainboard
Key Strengths
✓Established IVF-focused brand founded by experienced specialist Dr. Manika Khanna.
✓Pan-India presence with 30+ locations under a scalable hub-and-spoke model.
✓Comprehensive fertility portfolio including IVF, ICSI and IUI treatments.
✓Strong revenue growth and improving profitability in recent years.
✓Positioned in a fast-growing Indian IVF market with high projected growth.
Key Risks
⚠High contingent liabilities relative to net worth.
⚠Exposure to operational and legal risks inherent in healthcare services.
⚠High employee attrition and dependence on skilled doctors and embryologists.
⚠Significant dependence on promoters for leadership and brand value.
⚠Past negative cash flows and rising borrowings are impacting financial flexibility
Frequently Asked Questions
Should I apply for Gaudium IVF and Women Health Limited IPO?
Based on our analysis, our rating for Gaudium IVF and Women Health Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Gaudium IVF and Women Health Limited IPO?
High contingent liabilities relative to net worth. Exposure to operational and legal risks inherent in healthcare services. High employee attrition and dependence on skilled doctors and embryologists.
What are the strengths of Gaudium IVF and Women Health Limited IPO?
Established IVF-focused brand founded by experienced specialist Dr. Manika Khanna. Pan-India presence with 30+ locations under a scalable hub-and-spoke model. Comprehensive fertility portfolio including IVF, ICSI and IUI treatments.
What is the price band of Gaudium IVF and Women Health Limited IPO?
The price band for Gaudium IVF and Women Health Limited IPO is 75-79. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more